Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Liver Cirrhosis

Free Subscription 29.09.2025 2 BMC Gastroenterol 1 Gastroenterology 2 Hepatology 1 J Gastroenterol 3 J Hepatol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Gastroenterol

1. JAFREE SR, Naveed A, Ahsan H, Burhan SK, et al
   Predictors of health-seeking behavior in patients with chronic liver disease and a comparison of health-seeking based on patient-type.
   BMC Gastroenterol. 2025;25:642.
   PubMed         Abstract available
   
   
2. ZHANG Y, Luo M, Ming Y
   Global burden of cirrhosis and other chronic liver diseases caused by specific etiologies from 1990 to 2021.
   BMC Gastroenterol. 2025;25:641.
   PubMed         Abstract available
   
   

   
   Gastroenterology

3. KISSELEVA T, Ganguly S, Murad R, Wang A, et al
   Regulation of Hepatic Stellate Cell Phenotypes in MASH.
   Gastroenterology. 2025 Mar 20:S0016-5085(25)00528.
   PubMed         Abstract available
   
   

   
   Hepatology

4. PREMKUMAR M, Kajal K, Roy A, Izzy M, et al
   'Point-of-Care Ultrasound (POCUS) guided volume management and the effect of cirrhotic cardiomyopathy on acute kidney injury outcomes in cirrhosis'.
   Hepatology. 2025 Sep 23. doi: 10.1097/HEP.0000000000001524.
   PubMed         Abstract available
   
   
5. HAGHNEJAD V, Burke L, El Ouahabi S, Parker R, et al
   Reply: a prognostic model in patients with alcohol-related cirrhosis does exist.
   Hepatology. 2025 Sep 18. doi: 10.1097/HEP.0000000000001537.
   PubMed        
   
   

   
   J Gastroenterol

6. LEE J, Cha JH, Cho HS, Yang K, et al
   The PNPLA3 I148M variant is associated with immune cell infiltration and advanced fibrosis in MASLD: a prospective genotype-phenotype study.
   J Gastroenterol. 2025;60:1284-1295.
   PubMed         Abstract available
   
   

   
   J Hepatol

7. AKCA M, Ketenci YB, Demiroz H, Avcioglu U, et al
   Concerns on Rivaroxaban Use in Cirrhosis: Pharmacokinetic, Safety, and Bleeding Risk Considerations.
   J Hepatol. 2025 Sep 17:S0168-8278(25)02489-4. doi: 10.1016/j.jhep.2025.
   PubMed        
   
   
8. OCHOA-ALLEMANT P, Hubbard RA, Kaplan DE, Serper M, et al
   Cause-specific mortality in patients with steatotic liver disease in the United States.
   J Hepatol. 2025;83:860-869.
   PubMed         Abstract available
   
   
9. DIAZ LA, Alazawi W, Agrawal S, Arab JP, et al
   High inherited risk predicts age-associated increases in fibrosis in patients with MASLD.
   J Hepatol. 2025;83:849-859.
   PubMed         Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Liver Cirrhosis is free of charge.